PCI Biotech Holding ASA (PCIB.OL)
NOK 1.42
(-1.39%)
NOK 1.42
(-1.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.99 Million | - | - | - | - | - |
| Cost of Revenue | - | 633 Thousand | 2.54 Million | 2.2 Million | 955 Thousand | 5000.00 |
| Gross Profit | 2.99 Million | -633 Thousand | -2.54 Million | -2.2 Million | -955 Thousand | -5000.00 |
| Operating Expenses | 25.23 Million | 56.44 Million | 86.02 Million | 82.12 Million | 88.8 Million | 44.51 Million |
| Selling, General and Administrative Expenses | 9.6 Million | 16.44 Million | 20.59 Million | 13.91 Million | 14.88 Million | 13.76 Million |
| Research and Development Expenses | 15.62 Million | 44.75 Million | 71.7 Million | 75.57 Million | 83.31 Million | 40.33 Million |
| Other Expenses | - | -4.75 Million | -6.27 Million | -7.36 Million | -9.39 Million | -9.58 Million |
| Cost and Expenses | 25.23 Million | 56.44 Million | 86.02 Million | 82.12 Million | 88.8 Million | 44.51 Million |
| Operating Income | -22.24 Million | -56.44 Million | -86.02 Million | -82.12 Million | -88.8 Million | -44.51 Million |
| Interest Expense | 160 Thousand | 127 Thousand | 89 Thousand | 397 Thousand | 506 Thousand | 117 Thousand |
| Income Tax Expense | - | -1.35 Million | 89 Thousand | 397 Thousand | 506 Thousand | 9.85 Million |
| Earnings before Tax | -20.31 Million | -55.09 Million | -88.39 Million | -72.23 Million | -88.74 Million | -34.78 Million |
| Net Income | -20.31 Million | -53.74 Million | -88.48 Million | -72.63 Million | -89.25 Million | -34.78 Million |
| Earnings Per Share Basic | -0.54 | -1.44 | -2.37 | -1.95 | -2.40 | -1.25 |
| Earnings Per Share Diluted | -0.54 | -1.44 | -2.37 | -1.95 | -2.40 | -1.23 |
| Weighted Average Shares Outstanding | 37.32 Million | 37.32 Million | 37.32 Million | 37.28 Million | 37.22 Million | 27.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.32 Million | 37.32 Million | 37.32 Million | 37.28 Million | 37.22 Million | 28.35 Million |
| Gross Margin | 1.00 | - | - | - | - | - |
| EBIT Margin | -7.43 | - | - | - | - | - |
| Profit Margin | -6.79 | - | - | - | - | - |
| EBITDA | -22.22 Million | -54.1 Million | -82.69 Million | -69.63 Million | -85.11 Million | -44.51 Million |
| Earnings Before Tax Margin | -7.44 | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.71 Million | 1.71 Million | - | 1.28 Million | 1.28 Million | - |
| Cost of Revenue | - | - | 371 Thousand | 187 Thousand | - | 93 Thousand |
| Gross Profit | 1.71 Million | 1.71 Million | -371 Thousand | 1.09 Million | 1.28 Million | -93 Thousand |
| Operating Expenses | 5.84 Million | 5.84 Million | 24.86 Million | 6.05 Million | 6.05 Million | 6.32 Million |
| Selling, General and Administrative Expenses | 2.28 Million | 2.28 Million | - | 2.13 Million | 2.13 Million | 2.15 Million |
| Research and Development Expenses | 3.56 Million | 3.56 Million | - | 3.92 Million | 3.92 Million | 4.35 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 5.84 Million | 5.84 Million | 25.23 Million | 6.05 Million | 6.05 Million | 6.32 Million |
| Operating Income | -4.12 Million | -4.12 Million | -25.23 Million | -4.76 Million | -4.76 Million | -6.32 Million |
| Interest Expense | - | - | 160 Thousand | 66 Thousand | - | - |
| Income Tax Expense | - | - | - | - | - | 1000.00 |
| Earnings before Tax | -3.7 Million | -3.7 Million | -20.31 Million | -4.25 Million | -4.25 Million | -5.75 Million |
| Net Income | -3.7 Million | -3.7 Million | -20.31 Million | -4.25 Million | -4.25 Million | -5.75 Million |
| Earnings Per Share Basic | -0.10 | -0.10 | - | -0.11 | -0.11 | -0.15 |
| Earnings Per Share Diluted | -0.10 | -0.10 | - | -0.11 | -0.11 | -0.15 |
| Weighted Average Shares Outstanding | 37.32 Million | 37.32 Million | 37.32 Million | 37.32 Million | 37.32 Million | 37.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.32 Million | 37.32 Million | 37.32 Million | 37.32 Million | 37.32 Million | 37.32 Million |
| Gross Margin | 1.00 | 1.00 | - | 0.85 | 1.00 | - |
| EBIT Margin | -2.37 | -2.37 | - | -3.63 | -3.63 | - |
| Profit Margin | -2.16 | -2.16 | - | -3.31 | -3.31 | - |
| EBITDA | -4.05 Million | -4.05 Million | - | -4.67 Million | -4.67 Million | -6.23 Million |
| Earnings Before Tax Margin | -2.41 | -2.41 | - | -3.71 | -3.71 | - |
APLM
IDWM
PTXLF
603393
MEGACPO
ALVET